[Skip To Content]
[Website of the National Cancer Institute's Technology Transfer Center.  Partnering with Industry for Improved Public Health.]
  • Home
  • Collaborative Opportunities
  • Standard Forms and Agreements
  • Technology Transfer Training
  • Resources
  • Intellectual Property

Standard Forms and Agreements

Clinical Trial Agreement (CTA)

Clinical Trial Agreements are used when studies will be conducted to determine the safety and efficacy of new agents and devices. There are 2 different versions of the CTA. Select from the following:

  • Center for Cancer Research Intramural CTA: Used for clinical trails conducted at the NCI (Word)
  • Cancer Therapy Evaluation Program (CTEP) Extramural CTA: Used for clinical trials conducted at NCI funded institutions including cancer centers and cooperative groups where CTEP and Industry collaborate on the clinical development of agent. This agreement is available from the list of Model Agreements on the CTEP web site: http://ctep.cancer.gov/industry/model.html

Confidential Disclosure Agreement (CDA)

Used for the exchange of confidential information. There are 3 different versions of the CDA. Select from the following:

Cooperative Research and Development Agreement (CRADA)

CRADA is used when NIH and Industry collaborate to further develop a technology for commercialization. There are 3 different versions of the CRADA. Select from the following:

  • Standard CRADA: Used for collaborative studies of basic research.
    (Word)
  • Intramural Clinical Trial CRADA: Used for collaborative studies which include a clinical trial conducted at the NIH.
    (Word)
  • Extramural Clinical Trial CRADA: Used for collaborative studies which include a clinical trial conducted at NIH funded sites.
    (Word)

Employee Invention Report (EIR)

Used by NIH staff for reporting and evaluating inventions. (Word)

  • SAIC-Frederick Invention Report Coversheet This coversheet is for use by SAIC-Frederick staff only - to be completed and attached to an EIR.
    (PDF)

Materials Cooperative Research and Development Agreement (Materials CRADA)

Materials CRADA is a simpler form of CRADA, with no significant collaboration, for the use of a proprietary material in an NIH research project.
( Word)

Material Transfers

Material Transfers are used for the exchange of materials with outside organizations for research purposes. NIH Staff may use the following forms:

  • Simple Letter of Agreement (SLA) (PDF | Word)
  • Frequently asked questions about the SLA.
  • The NIH Material Transfer Agreement (MTA)
    (PDF | Word)
  • Material Transfer Agreement for the Transfer of Organisms (MTA-TO)
    MTA-TO is used for the exchange of organisms with outside organizations for research purposes. (Word)

Natural Products Branch-Developmental Therapeutics Program Memorandum of Understanding (MOU)

The Natural Products Program Memorandum of Understanding is used when a foreign institution provides extracts and /or pure compounds directly to the NCI for antitumor screening and evaluation. (Word)

The Letter of Collection (LOC)

The Letter of Collection is an agreement between the NCI Developmental Therapeutics Program Natural Products Branch and a Source Country (or institution therein) describing the process of collecting samples of the country's biodiversity (plant, marine, microbial) through an approved collection contractor and screening them at the NCI for cancer and other disease targets. (Word)

See Also:

Providing Trademark Services for the Public Health Service
(Note: This link will transfer you to the Intellectual Property section of the site.)

Trademark Request Form
(Note: This link will transfer you to the Intellectual Property section of the site.)


Page Last Updated: 12-22-2008